Opioid-Prescribing Continuity and Risky Opioid Prescriptions

Authors

Sara E. Hallvik, HealthInsight OregonFollow
Peter Geissert, Portland State UniversityFollow
Wayne Wakeland, Portland State UniversityFollow
Christi Hildebran, HealthInsight Oregon
Jody Carson, HealthInsight Oregon
Nicole O'Kane, HealthInsight Oregon
Richard A. Deyo, Oregon Health and Science UniversityFollow

Sponsor

R01 DA031208/DA/NIDA NIH HHS/United States

Published In

Annals of Family Medicine

Document Type

Citation

Publication Date

9-1-2018

Abstract

We aimed to better understand the association between opioid-prescribing continuity, risky prescribing patterns, and overdose risk. For this retrospective cohort study, we included patients with long-term opioid use, pulling data from Oregon's Prescription Drug Monitoring Program (PDMP), vital records, and hospital discharge registry. A continuity of care index (COCI) score was calculated for each patient, and we defined metrics to describe risky prescribing and overdose. As prescribing continuity increased, likelihood of filling risky opioid prescriptions and overdose hospitalization decreased. Prescribing continuity is an important factor associated with opioid harms and can be calculated using administrative pharmacy data.

Locate the Document

https://doi.org/10.1370/afm.2285.

DOI

10.1370/afm.2285.

Persistent Identifier

https://archives.pdx.edu/ds/psu/26580

Citation Details

Hallvik, S. E., Geissert, P., Wakeland, W., Hildebran, C., Carson, J., O’Kane, N., & Deyo, R. A. (2018). Opioid-prescribing continuity and risky opioid prescriptions. The Annals of Family Medicine, 16(5), 440-442.